Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Cardiorespiratory Response During Whole Body Vibration Training in Patients With Chronic Lung Disease

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01898143
Recruitment Status : Completed
First Posted : July 12, 2013
Last Update Posted : February 24, 2016
Sponsor:
Information provided by (Responsible Party):
Klaus Kenn, Schön Klinik Berchtesgadener Land

Brief Summary:
Whole body vibration training seems to be a useful adjunct in exercise training in patients with severe COPD. The basic principle relies on reflectory muscle contractions caused by a vibration stimulus. Until now the impact of whole body vibration training on cardiopulmonary parameters remained unknown. Therefore aim of this study is to investigate cardiopulmonary parameters during whole body vibration training in patients with chronic lung disease.

Condition or disease Intervention/treatment Phase
Chronic Obstructive Lung Disease (n=10) Interstitial Lung Disease (n=10) Other: Whole body vibration Not Applicable

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 10 participants
Allocation: Non-Randomized
Intervention Model: Single Group Assignment
Masking: Single (Outcomes Assessor)
Primary Purpose: Diagnostic
Official Title: Cardiorespiratory Response During Whole Body Vibration Training in Patients With Chronic Obstructive Pulmonary Disease (COPD) or Interstitial Lung Disease (ILD)
Study Start Date : June 2013
Actual Primary Completion Date : May 2015
Actual Study Completion Date : May 2015

Resource links provided by the National Library of Medicine


Arm Intervention/treatment
Whole body vibration in COPD
Patients with COPD GOLD III or IV
Other: Whole body vibration
Whole body vibration in ILD
PAtients with interstitial lung disease
Other: Whole body vibration



Primary Outcome Measures :
  1. peak oxygen consumption (VO2 peak) [ Time Frame: during 1 exercise session ]
    subjects perform several short bouts (1 to 3 minutes duration) of squatting exercise with or without whole body vibration. The peak values of each single part is used for comparison.


Secondary Outcome Measures :
  1. heart rate (HR) [ Time Frame: during 1 exercise session ]
    subjects perform several short bouts (1 to 3 minutes duration) of squatting exercise with or without whole body vibration. The peak values of each single part is used for comparison.

  2. minute ventilation (VE) [ Time Frame: during 1 exercise session ]
    subjects perform several short bouts (1 to 3 minutes duration) of squatting exercise with or without whole body vibration. The peak values of each single part is used for comparison.

  3. perceived exertion for dyspnea and leg fatigue (Borg-scale) [ Time Frame: during 1 exercise session ]
    subjects perform several short bouts (1 to 3 minutes duration) of squatting exercise with or without whole body vibration. The peak values of each single part is used for comparison.

  4. Alveolar-arterial oxygen difference (AaDO2) [ Time Frame: during 1 exercise session ]
    subjects perform several short bouts (1 to 3 minutes duration) of squatting exercise with or without whole body vibration. The peak values of each single part is used for comparison.

  5. breathing frequency (BF) [ Time Frame: during 1 exercise session ]
    subjects perform several short bouts (1 to 3 minutes duration) of squatting exercise with or without whole body vibration. The peak values of each single part is used for comparison.

  6. peak carbon-dioxide consumption (VCO2 peak) [ Time Frame: during 1 exercise session ]
    subjects perform several short bouts (1 to 3 minutes duration) of squatting exercise with or without whole body vibration. The peak values of each single part is used for comparison.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   20 Years to 75 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • COPD stage III or IV according to the Global Initiative for chronic obstructive lung disease [GOLD])
  • Interstitial Lung disease (forced vital capacity (FVC) < 70% pred., diffusion capacity of lung for carbon monoxide (DLCO) 30-70% pred.)

Exclusion Criteria:

  • Oxygen therapy during exercise required
  • Severe exacerbation of lung disease, with necessity of change in medication or persistent symptoms > 3days
  • activated arthrosis /arthropathy/ rheumatoid Arthritis/ acute discopathy
  • acute thrombosis
  • acute musculoskeletal inflammation
  • Epilepsy
  • Gallstones

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01898143


Locations
Layout table for location information
Germany
Schön Klinik Berchtesgadener Land
Schönau am Königssee, Germany, 83471
Sponsors and Collaborators
Schön Klinik Berchtesgadener Land
Layout table for additonal information
Responsible Party: Klaus Kenn, Head Physican (department of pneumology), Schön Klinik Berchtesgadener Land
ClinicalTrials.gov Identifier: NCT01898143    
Other Study ID Numbers: SpiroErgoGalileo-2013
First Posted: July 12, 2013    Key Record Dates
Last Update Posted: February 24, 2016
Last Verified: February 2016
Keywords provided by Klaus Kenn, Schön Klinik Berchtesgadener Land:
Whole body vibration, cardiorespiratory response
Additional relevant MeSH terms:
Layout table for MeSH terms
Lung Diseases
Lung Diseases, Interstitial
Lung Diseases, Obstructive
Pulmonary Disease, Chronic Obstructive
Respiratory Tract Diseases